Drug Shortage Report for ATROPINE SULFATE INJECTION USP
Report ID | 159096 |
Drug Identification Number | 00392693 |
Brand name | ATROPINE SULFATE INJECTION USP |
Common or Proper name | ATROPINE SO4 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | .6MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIAM |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-04-20 |
Actual start date | |
Estimated end date | 2022-07-08 |
Actual end date | 2022-07-13 |
Shortage status | Resolved |
Updated date | 2022-07-14 |
Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-07-14 | English | Compare |
v9 | 2022-07-13 | French | Compare |
v8 | 2022-07-13 | English | Compare |
v7 | 2022-04-27 | French | Compare |
v6 | 2022-04-27 | English | Compare |
v5 | 2022-04-20 | French | Compare |
v4 | 2022-04-20 | English | Compare |
v3 | 2022-04-20 | French | Compare |
v2 | 2022-04-20 | French | Compare |
v1 | 2022-04-20 | English | Compare |
Showing 1 to 10 of 10